Cargando…
Ivermectin: Acute hepatocellular injury following off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733806/ http://dx.doi.org/10.1007/s40278-022-08555-4 |
Ejemplares similares
-
Azithromycin/ivermectin: Mixed hearing loss following off-label use: case report
Publicado: (2022) -
Ivermectin: Anti-neutrophil cytoplasmic antibody-associated vasculitis following off label use: case report
Publicado: (2021) -
Lopinavir/ritonavir: Acute hepatocellular hepatitis following off-label use in COVID-19: case report
Publicado: (2020) -
Favipiravir: Liver injury following an off-label use: case report
Publicado: (2021) -
Azithromycin/lopinavir/ritonavir: Acute kidney injury following off label use: case report
Publicado: (2021)